Table 4.
(A) Add CXCL12 to model | ||||||
ROC AUC in Model 2 | ROC AUC in Model 2 + eGFR | |||||
Without CXCL12 | With CXCL12 | P-value | Without CXCL12 | With CXCL12 | P-value | |
Probable MI | 0.664 | 0.685 | 0.003 | 0.690 | 0.698 | 0.023 |
Death | 0.674 | 0.695 | <0.001 | 0.723 | 0.727 | 0.049 |
MI or death | 0.660 | 0.680 | <0.001 | 0.703 | 0.707 | 0.057 |
(B) Add eGFR to model | ||||||
ROC AUC in Model 2 | ROC AUC in Model 2 + CXCL12 | |||||
Without eGFR | With eGFR | P-value | Without eGFR | With eGFR | P-value | |
Probable MI | 0.664 | 0.690 | 0.002 | 0.685 | 0.698 | 0.017 |
Death | 0.674 | 0.723 | <0.001 | 0.695 | 0.727 | <0.001 |
MI or death | 0.660 | 0.703 | <0.001 | 0.680 | 0.707 | <0.001 |
aStandardized plasma CXCL12 values.
Model 2: CXCL12 + demographic factors + traditional risk factors (diabetes, hypertension, hypercholesterolaemia, tobacco use, body mass index).